Skip to main content

Advertisement

Log in

Adverse effects of drug therapies on male and female sexual function

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Sexual dysfunctions (SD) are adverse effects of common drug therapies that have rarely been considered in investigations so far. Possibly it is barely known that many widespread and frequently prescribed medications and drug therapies can have significant impact on vascular and nerval processes as well as on endocrinologic and psychoneuroendocrinologic systems and therefore can influence sexual functions. Impotence and disorders of the erectile function can mainly be caused by antidopaminergic mechanisms, whereas ejaculatory disorders and anorgasmia often can be explained by antiserotoninergic effects. Anticholinergic and adrenoloytic agents can also cause a particular impairment of erectile functions. The following considerations will show that the detection and treatment of SD (also in women!) should be given much more attention since drug-induced SDs occur predominantly in indications where a SD itself can be a symptom of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Giuliano F, Allard J (2001) Dopamine and male sexual function. Eur Urol 40:601–608

    Article  CAS  PubMed  Google Scholar 

  2. Papatsoris AG, Korantzopoulos PG (2006) Hypertension, antihypertensive therapy and erectile dysfunction. Angiology 57:47–52

    Article  PubMed  Google Scholar 

  3. Stevenson JG, Umstead GS (1984) Sexual dysfunction due to antihypertensive agents. Drug Intell Clin Pharm 18:113–121

    CAS  PubMed  Google Scholar 

  4. Chang SW, Fine R, Siegel D (1991) The impact of diuretic therapy on reported sexual function. Arch Intern Med 151:2402–2408

    Article  CAS  PubMed  Google Scholar 

  5. Loriaux DL, Menard R, Taylor A (1976) Spironolactone and endocrine dysfunction. Ann Intern Med 85:630–636

    CAS  Google Scholar 

  6. Smith PJ, Talbert RL (1986) Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm 5:373–384

    CAS  PubMed  Google Scholar 

  7. Kolodny RC (1987) Effects of alpha-methyldopa on male sexual function. Sex Disabil 1:223–227

    Article  Google Scholar 

  8. Newman RJ, Salerno HR (1974) Sexual dysfunction due to methyldopa. Br Med J 4:106

    Article  CAS  PubMed  Google Scholar 

  9. Bansal S (1988) Sexual dysfunction in hypertensive men: a critical review of the literature. Hypertension 12:1–10

    CAS  PubMed  Google Scholar 

  10. Della Chiesa A, Pfiffner D, Meier B (2003) Sexual activity in hypertensive men. J Hum Hypertens 17:515–521

    Article  CAS  PubMed  Google Scholar 

  11. Ferrario CM, Levy P (2002) Sexual dysfunction in patients with hypertension: implications for therapy. J Clin Hypertens (Greenwich) 4:424–432

    Article  Google Scholar 

  12. Speel TGW, Kiemeney LA, Thien T, Smits P, Meuleman EJ (2005) Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study. J Sex Med 2:207

    Article  CAS  PubMed  Google Scholar 

  13. Giraldi AG, Victor J (2002) Female sexual dysfunction as adverse effect of pharmacological treatment. Ugeskr Laeger 164:4757–4760

    PubMed  Google Scholar 

  14. Brindis RG, Kloner RA (2003) Sildenafil in patients with cardiovascular disease. Am J Cardiol 92(Suppl.):26–36

    Article  Google Scholar 

  15. Kloner RA, Mitchell M, Emmick JT (2003) Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol 92(Suppl.):47–57

    Article  CAS  Google Scholar 

  16. Aranda P, Ruilope LM, Calvo C (2004) Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens 17:139–145

    Article  CAS  PubMed  Google Scholar 

  17. McLaughlin T, Harnett J, Burhani S, Scott B (2005) Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther 12:605–611

    Article  PubMed  Google Scholar 

  18. Weiss RJ (1991) Effects of antihypertensive agents on sexual function. Am Fam Physician 44:2075–2082

    CAS  PubMed  Google Scholar 

  19. van Dijk MM, de la Rosette JJ, Michel MC (2006) Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs 66:287–301

    Article  PubMed  Google Scholar 

  20. Clayton AH, Montejo AL (2006) Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 67(Suppl. 6):33–37

    PubMed  Google Scholar 

  21. Rosen RC, Marin H (2003) Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 64:5–10

    Article  PubMed  Google Scholar 

  22. Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ (2005) Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66:686–692

    Article  PubMed  Google Scholar 

  23. Waldinger MD, Zwinderman AH, Olivier B (2003) Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 23:467–470

    Article  CAS  PubMed  Google Scholar 

  24. Michael A, Andrews S (2002) Paroxetine-induced vaginal anaesthesia. Pharmacopsychiatry 35:150–151

    Article  CAS  PubMed  Google Scholar 

  25. Capasso R, Borrelli F, Montanaro V, Altieri V, Capasso F, Izzo AA (2005) Effects of the antidepressant St. John’s wort (Hypericum perforatum) on rat and human vas deferens contractility. J Urol 173:2194–2197

    Article  CAS  PubMed  Google Scholar 

  26. Worthington JJ 3rd, Peters PM (2003) Treatment of antidepressant-induced sexual dysfunction. Drugs Today 39:887–896

    Article  CAS  PubMed  Google Scholar 

  27. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ (2006) Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 67:240–246

    Article  CAS  PubMed  Google Scholar 

  28. Khawaja MY (2005) Sexual dysfunction in male patients taking antipsychotics. J Ayub Med Coll Abbottabad 17:73–75

    PubMed  Google Scholar 

  29. Higgins A, Barker P, Begley CM (2005) Neuroleptic medication and sexuality: the forgotten aspect of education and care. J Psychiatr Ment Health Nurs 12:439–446

    Article  CAS  PubMed  Google Scholar 

  30. Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA (2006) Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology 31:577–588

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Th. Stadler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stadler, T., Bader, M., Ückert, S. et al. Adverse effects of drug therapies on male and female sexual function. World J Urol 24, 623–629 (2006). https://doi.org/10.1007/s00345-006-0136-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-006-0136-5

Keywords

Navigation